Bicycle Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $887 | $47,955 | $11,734 | $2,920 |
Gross Profit | 887 | 47,955 | 11,734 | -68,109 |
EBITDA | -59,476 | -17,496 | -57,095 | -77,433 |
EBIT | -60,605 | -18,832 | -58,851 | -79,129 |
Net Income | -60,825 | -20,154 | -59,100 | -78,952 |
Net Change In Cash | 887 | 47,955 | 11,734 | 2,920 |
Free Cash Flow | -66,638 | -17,236 | -71,847 | -73,284 |
Cash | 559,474 | 628,110 | 648,325 | 721,451 |
Basic Shares | 69,683 | 69,364 | 69,303 | 69,252 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $72,586 | $35,275 | $26,976 | $14,463 |
Gross Profit | 72,586 | -137,691 | -129,520 | 14,463 |
EBITDA | -212,180 | -164,892 | -183,400 | -107,208 |
EBIT | -218,602 | -172,069 | -189,946 | -110,897 |
Net Income | -218,960 | -169,031 | -180,664 | -112,717 |
Net Change In Cash | 72,586 | 35,275 | 26,976 | 14,463 |
Free Cash Flow | -252,613 | -165,959 | -63,557 | -105,098 |
Cash | 628,110 | 879,520 | 526,423 | 339,154 |
Basic Shares | 69,279 | 58,207 | 35,592 | 29,660 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.87 |
2025-12-31 | -$0.29 |
2025-09-30 | -$0.85 |
2025-06-30 | -$1.14 |